Symbol="RVLP"
AssetType="Common Stock"
Name="RVL Pharmaceuticals PLC"
Description="RVL Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina and Hungary. The company is headquartered in Bridgewater, New Jersey."
CIK="1739426"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="400 CROSSING BOULEVARD, BRIDGEWATER, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="41230200"
EBITDA="-44496000"
PERatio="None"
PEGRatio="None"
BookValue="0.403"
DividendPerShare="0"
DividendYield="0"
EPS="-0.57"
RevenuePerShareTTM="0.396"
ProfitMargin="-1.522"
OperatingMarginTTM="-1.209"
ReturnOnAssetsTTM="-0.22"
ReturnOnEquityTTM="-1.032"
RevenueTTM="37109000"
GrossProfitTTM="43065000"
DilutedEPSTTM="-0.57"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.588"
AnalystTargetPrice="3.2"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.921"
PriceToBookRatio="1.938"
EVToRevenue="3.034"
EVToEBITDA="-2.697"
Beta="0.964"
num_52WeekHigh="2.99"
num_52WeekLow="0.36"
num_50DayMovingAverage="0.676"
num_200DayMovingAverage="1.125"
SharesOutstanding="99350000"
DividendDate="None"
ExDividendDate="None"
symbol="RVLP"
open="0.42"
high="0.47"
low="0.40"
price="0.45"
volume="170406.00"
latest_trading_day="2023-08-01"
previous_close="0.40"
change="0.05"
change_percent="11.9950%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="90"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="10"
Volume_recent_avg="80839"
Change_recent_avg="-0.01"
Delta_recent_avg="0.08"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-1.24"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="10"
Aroon_momentum_negative="90"
image_negative_thumbnail_id_1="515"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0090.jpeg"
image_negative_thumbnail_id_2="509"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_neutral_thumbnail_id_1="593"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0006.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="973"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0135.jpeg"
image_positive_thumbnail_id_2="620"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0088.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
